ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: SA-PO0805

Revisiting the Prognosis of Patients with IgAN and Mild Proteinuria: Longitudinal Study with Unexpected Outcomes

Session Information

Category: Glomerular Diseases

  • 1402 Glomerular Diseases: Clinical, Outcomes, and Therapeutics

Authors

  • Ma, Xiuhua, General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China
  • Zhang, Sen, General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China
  • Zhou, Xiaoling, General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China
Background

IgA nephropathy (IgAN) is the most prevalent form of primary glomerulonephritis and a leading cause of chronic kidney disease (CKD) globally.Current research primarily focuses on high-risk IgAN populations,while those with mild proteinuria are often considered to have a favorable prognosis. However, recent evidence suggests that patients with urinary protein excretion<0.5g/day may still be at significant risk of disease progression.

Methods

Retrospective analysis of 265 biopsy-proven IgAN patients (August 2008–December 2023) with urinary protein≤0.5g/24h,≥12-month follow-up, and no steroid/immunosuppressive therapy.Patients were stratified into two groups based on the occurrence of composite renal endpoint events.

Results

The study included 265 IgAN patients (50.6% male,mean age 37.5±12.0years).At biopsy,26.8% had hypertension and 64.2% received RASi.Most were CKD stage 1 (61.5%) and CKM stage 2 (68.3%).Baseline parameters:proteinuria 0.3±0.1g/24h,SCr 82.0±27.7μmol/L,eGFR 97.3±24.8mL/min/1.73m2,and TyG-BMI 202.4±39.1.
Pathological findings according to the Oxford Classification included S1 in 31.3%,T1+T2 in 27.5%,C1+C2 in 35.1%.Renal arteriolar lesions were identified in 130 patients(49.1%),with Lee's grade III being most predominant(41.9%).
During a mean follow-up of 90.8±52.8months,2 patients died,10 progressed to ESRD,and 15 experienced a>30% decline in eGFR.The mean annual eGFR decline rate was -2.3±11.1mL/min/1.73 m2/year.The Clinicopathological features of the composite renal endpoint event group are worse, and the CKM stage is more severe.Multivariable logistic regression identified higher creatinine levels,T1+T2 proportion,and lower TyG-BMI as independent risk factors for composite renal endpoint events.Cox regression analysis revealed that higher diastolic blood pressure,creatinine levels,renal arteriolar lesion proportion,and lower TyG-BMI were independent risk factors for composite endpoint events.

Conclusion

Our study challenges the favorable prognosis assumption in IgAN patients with mild proteinuria.Over 90.8 months' follow-up,10.2% reached composite endpoints,demonstrating significant progression risk.We found that metabolic factors,such as lower TyG-BMI and higher CKM stage,are also important predictors of prognosis,in addition to traditional risk factors like baseline renal function and tubulointerstitial lesion severity.

Digital Object Identifier (DOI)